aNeurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health
bDepartment of Psychiatry, University of Toronto
cInstitute of Medical Science, Faculty of Medicine, University of Toronto
dLaboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
eStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
fThe Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
gProgram in Genetics and Genomic Biology and Department of Psychiatry, The Hospital for Sick Children
hDepartment of Psychiatry, Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Science Centre, Toronto, ON, Canada
iDepartment of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA
jDepartment of Psychiatry & Behavioral Neurosciences, Wayne State University, Detroit, Michigan, USA
Received 13 January 2023 Accepted 29 March 2023.
Correspondence to Dr. Gwyneth Zai, MD, FRCPC, PhD, Neurogenetics Section, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON M5 1R8, Canada Tel: 1 + 416 535 8501; fax: +1 416 979 4666; e-mail: [email protected]
